Compare QCOM & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QCOM | MDT |
|---|---|---|
| Founded | 1985 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.4B | 131.9B |
| IPO Year | 2009 | 2014 |
| Metric | QCOM | MDT |
|---|---|---|
| Price | $146.35 | $96.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 19 |
| Target Price | ★ $170.89 | $109.82 |
| AVG Volume (30 Days) | ★ 10.0M | 8.5M |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | 2.44% | ★ 2.94% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | ★ 2.78 | 2.76 |
| Revenue | ★ $44,284,000,000.00 | $33,537,000,000.00 |
| Revenue This Year | $0.90 | $8.57 |
| Revenue Next Year | $0.77 | $5.86 |
| P/E Ratio | $52.48 | ★ $35.02 |
| Revenue Growth | ★ 13.66 | 3.62 |
| 52 Week Low | $120.80 | $79.55 |
| 52 Week High | $205.55 | $106.33 |
| Indicator | QCOM | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 46.81 | 42.34 |
| Support Level | $142.94 | $95.10 |
| Resistance Level | $149.30 | $100.35 |
| Average True Range (ATR) | 3.49 | 2.07 |
| MACD | 1.54 | -0.49 |
| Stochastic Oscillator | 96.26 | 20.06 |
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.